To further characterize the expression levels and patterns of IGF-II in cancer, we turned to the DepMap expression database, a publicly available tool managed by the Broad Institute [31] (available at https://depmap.org/portal/ accessed on 24 September 2023), and focused on a few key parameters conveyed in Figure 3. This evidence concerns the gene IGF2 and cancer.